About Amy Ripka
Form D filings for Lucy Therapeutics from 2019 to 2024 list Amy Ripka as president and director.
Amy Ripka first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Amy Ripka in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Amy Ripka works with at each company, as listed on that company's latest Form D.
Lucy Therapeutics, Inc. · Form D/A, May 2, 2024